International stocks trading in New York closed lower on
Thursday, with the Bank of New York index of American depositary
receipts down 0.54% to 153.76. The European index eased 0.41% to
154.07, the Asian index fell 0.57% to 143.04, the Latin American
index dropped 1.5% to 293.56 and the emerging markets index
declined 1% to 283.61. Among the companies with shares that
actively traded was Gol Linhas Aereas Inteligentes SA (GOL,
GOLL4.BR).
Brazilian budget airline Gol reported a first-quarter loss due
to an increase in costs, and the airline said it is planning more
international flights to increase its foreign currency revenue.
Shares rose 0.2% to $6.39.
Novartis AG (NVS, NOVN.VX) has managed to push back generic
competition in the U.S. to its blockbuster leukemia drug Gleevec
for about seven months. Financial terms of the Swiss drug maker's
patent litigation settlement agreement with Sun Pharmaceuticals
Industries Ltd. weren't disclosed. Novartis shares rose 0.8% to
$89.93.
Siemens AG (SI, SIE.XE) said it received an order valued at 1.5
billion euros ($2.06 billion) for wind turbines to power the
largest Dutch offshore project to date. Shares of the German
engineering conglomerate fell 1.2% to $132.66.
Nokia Corp. (NOK, NOK1V.HE) said that 5,000 employees at its
factory in the southern Indian city of Chennai have opted for a
severance package after Wednesday's deadline passed. The
Helsinki-based company offered employees a severance option after
Indian authorities excluded the factory from the sale of Nokia's
handset business to Microsoft Corp. Nokia shares fell 0.3% to
$7.26.
Barclays PLC's (BCS, BARC.LN) top Asia rainmaker, brought in to
build out its regional investment banking business five years ago,
is stepping down, the latest key executive to depart the U.K.
lender's regional business. Shares fell 1.5% to $16.51.
AstraZeneca PLC (AZN, AZN.LN) said it is making progress in
accelerating its late stage pipeline, as the U.K. pharmaceutical
company issued its latest retort to Pfizer Inc.'s $106 billion bid.
Shares rose 2.9% to $80.52.
Write to Anna Prior at anna.prior@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires